Insider Transactions in Q1 2023 at Mersana Therapeutics, Inc. (MRSN)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 17
2023
|
Anna Protopapas Director |
SELL
Open market or private sale
|
Direct |
17,346
-26.25%
|
$86,730
$5.74 P/Share
|
|
Jan 17
2023
|
Arvin Yang SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,209
-6.69%
|
$11,045
$5.74 P/Share
|
|
Jan 17
2023
|
Ashish Mandelia VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,575
-20.79%
|
$17,875
$5.74 P/Share
|
|
Jan 17
2023
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
6,233
-3.34%
|
$31,165
$5.74 P/Share
|
|
Jan 17
2023
|
Tushar Misra SVP, Chief Manuf. Officer |
SELL
Open market or private sale
|
Direct |
458
-7.17%
|
$2,290
$5.74 P/Share
|
|
Jan 17
2023
|
Alejandra Carvajal SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
782
-6.63%
|
$3,910
$5.74 P/Share
|
|
Jan 17
2023
|
Brian De Schuytner SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
5,131
-13.53%
|
$25,655
$5.74 P/Share
|
|
Jan 15
2023
|
Anna Protopapas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
38,958
+25.83%
|
-
|
|
Jan 15
2023
|
Ashish Mandelia VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,352
+13.13%
|
-
|
|
Jan 15
2023
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,209
+4.0%
|
-
|
|
Jan 15
2023
|
Brian De Schuytner SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,208
+12.5%
|
-
|
|
Jan 14
2023
|
Anna Protopapas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,750
+38.18%
|
-
|
|
Jan 14
2023
|
Arvin Yang SVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,084
+17.66%
|
-
|
|
Jan 14
2023
|
Ashish Mandelia VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,784
+28.77%
|
-
|
|
Jan 14
2023
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,792
+2.72%
|
-
|
|
Jan 14
2023
|
Tushar Misra SVP, Chief Manuf. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,459
+18.59%
|
-
|
|
Jan 14
2023
|
Alejandra Carvajal SVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+17.48%
|
-
|
|
Jan 14
2023
|
Brian De Schuytner SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+18.41%
|
-
|